We are live on ! Find out more
ASTH icon

Astrana Health

188 hedge funds and large institutions have $759M invested in Astrana Health in 2025 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 64 increasing their positions, 57 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,530% more call options, than puts

Call options by funds: $16.3M | Put options by funds: $997K

129% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 21

18% more capital invested

Capital invested by funds: $642M → $759M (+$117M)

16% more funds holding

Funds holding: 162188 (+26)

12% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 57

1.76% more ownership

Funds ownership: 45.94%47.7% (+1.8%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
188
Holders Change
+26
Holders Change %
+16.05%
% of All Funds
2.47%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
48
Increased
64
Reduced
57
Closed
21
Calls
$16.3M
Puts
$997K
Net Calls
+$15.3M
Net Calls Change
+$3.27M

ASTH Hedge Fund Activity: Q3 2025 in Review

188 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q3 2025, worth a combined $759M — up 18% from $642M a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new ASTH positions and 21 closed out — a net gain of 27 holders — while 64 added to existing stakes and 57 trimmed.

The largest buyer was Ameriprise, adding an estimated $8.36M. The largest seller was Rhenman & Partners Asset Management, exiting entirely with an estimated $4.73M sold.

  • 188 institutional investors held Astrana Health (ASTH) as of Q3 2025, up from 162 in Q2 2025.
  • Funds reported $759M of Astrana Health stock for Q3 2025, up 18% quarter-over-quarter.
  • 48 funds opened new Astrana Health positions in Q3 2025 and 21 closed out, a net change of +27 holders.
  • The largest Astrana Health buyer in Q3 2025 was Ameriprise, an estimated $8.36M added.
  • The largest Astrana Health seller in Q3 2025 was Rhenman & Partners Asset Management, an estimated $4.73M sold.

Based on aggregated 13F filings for Q3 2025.